Electrochemical cell design: Turning electron transfer into a practical synthetic tool
Explore electrochemical cell design, electron transfer, process development, and scalable pharmaceutical synthesis. Read the article.
From Faster CLD to Smarter CMC Decisions: How Semi-Targeted Integration Changes the Biologics Game
See how semi-targeted integration can improve cell line development, reduce clone screening, and support biologics development. Read the article.
India as a Global CRDMO Powerhouse: Debunking Quality Myths
Explore how India’s CRDMO quality systems, regulatory scrutiny, and biologics manufacturing capabilities challenge outdated quality myths. Read more.
Oligonucleotide Analytical Development: Five Hidden Traps and How to Avoid Them
Avoid five analytical traps in oligonucleotide development, from impurity profiling to bioanalysis and validation. Read more.
Direct to Biology for Drug Discovery Acceleration: Syngene’s D2B Platform
Publication: Pharmaceutical Technology Focus
Electrochemical Synthesis of Self-immolative Methylene Alkoxy Carbamate (MAC) to Facilitate Construction of Antibody–drug Conjugate Linkers with Alcohol-containing Payloads
Publication: Thieme
Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
Publication: Fierce Pharma
Forging the Future: Why Strategic Outsourcing in Biologics is No Longer Optional, It’s Essential for Success
Publication: Fierce Biotechnology
Allometric scaling vs PBPK: when each approach helps in human dose prediction
Compare allometric scaling and PBPK for human dose prediction using in vivo data and mechanistic models. Read more.
From PBPK modeling to first-in-human dose: how predictive DMPK can reduce early clinical risk
Explore how PBPK modeling supports human PK prediction, first-in-human dose selection, and model-informed drug development. Read more.